Souhaitez-vous accéder aux communiqués récents ?

NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t

SAN DIEGO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer,...

CTX-8371, a novel dual checkpoint blocker that simultaneously targets the programmed death receptor PD-1 and its ligand PD-L1, demonstrated promising monotherapy clinical activity in patients with...

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- CapeHaven, LLC, a New Haven-based biotech venture creation platform, announced today that it has completed a first close on the path toward its...

Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By...

Nanomedicine expert joins Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease

Austin, TX, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Compression Garments and Stockings Market Size, Trends and Insights By Product...

Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or...

Eascra Biotech, a nanomedicine startup, has won first place at the TechConnect Bio in Space Innovation Challenge